Aposense Ltd.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Chinook Well Capitalized To Advances It

For biotechs of a certain ilk – older than five years with a mid-to-late stage clinical program – the decision to test the public waters may feel like a Hobson’s choice. Assuming the start-up’s ventur

In Vitro Diagnostics Acquisitions